Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upArndt Vogel, Erika Martinelli, Andrés Cervantes et al.|Annals of Oncology|2018Cited by 1.1k
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trialCarlotta Antoniotti, Chiara Cremolini, Federica Marmorino et al.|The Lancet Oncology|2022Cited by 268
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN StudyEric Van Cutsem, Alberto Zaniboni, Erika Martinelli et al.|The Oncologist|2018Cited by 143
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancerTakayuki Yoshino, George Pentheroudakis, Guillem Argilés et al.|Annals of Oncology|2021Cited by 87